Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994-2013).

PMID: 30536209
Journal: Clinical & Translational Oncology
Year: 2019
Reference: Clin Transl Oncol. 2019 Jul;21(7):891-899. doi: 10.1007/s12094-018-1994-1. Epub 2018 Dec 10.
Impact factor:
Publication type: Paper in international publication
Authors: Carbo, A; Comas, R; Izquierdo, A; Marcos-Gragera, R; Pinheiro, P S; Pla, H; Roca-Barcelo, A; Solans, M; Vilardell, L; Vinas, G et al.
DOI: 10.1007/s12094-018-1994-1

Mosunetuzumab Induces Complete Remissions in Poor Prognosis Non-Hodgkin Lymphoma Patients, Including Those Who Are Resistant to or Relapsing After Chimeric Antigen Receptor T-Cell (CAR-T) Therapies, and Is Active in Treatment through Multiple Lines.

PMID: 31723992
Journal: BLOOD
Year: 2019
Reference: Blood. 2019 Nov 13;134(Supplement_1):6. doi: 10.1182/blood-2019-123742.
Impact factor: 16.562
Publication type: Paper in international publication
Authors: Bartlett, Nancy L, Assouline, Sarit, Yoon, Sung-Soo, Bosch, Francesc, Sehn, Laurie H, Cheah, Chan Y, Shadman, Mazyar, Gregory, Gareth P, Ku, Matthew, Wei, Michael C et al.
DOI: 10.1182/blood-2019-123742

Mosunetuzumab Induces Complete Remissions in Poor Prognosis Non-Hodgkin Lymphoma Patients, Including Those Who Are Resistant to or Relapsing After Chimeric Antigen Receptor T-Cell (CAR-T) Therapies, and Is Active in Treatment through Multiple Lines.

PMID: 31723992
Journal: BLOOD
Year: 2019
Reference: Blood. 2019 Nov 13;134(Supplement_1):6. doi: 10.1182/blood-2019-123742.
Impact factor:
Publication type: Paper in international publication
Authors: Assouline, Sarit; Bartlett, Nancy L; Bosch, Francesc; Budde, Lihua E; Cheah, Chan Y; Gregory, Gareth P; Hernandez, Genevive; Ku, Matthew; Kwan, Antonia; Li, Chi-Chung et al.
DOI: 10.1182/blood-2019-123742

Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia.

PMID: 30689894
Journal: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Year: 2019
Reference: J Antimicrob Chemother. 2019 Apr 1;74(4):1101-1107. doi: 10.1093/jac/dky556.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez-Fernandez, Maximiliano; Baroja, Aida; Crespo, Manuel; Lopez-Cortes, Luis Eduardo; Martinez-Lamas, Lucia; Nodar, Andres; Perez-Rodriguez, Maria Teresa; Rodriguez-Bano, Jesus; Sousa, Adrian; Val, Nuria et al.
DOI: 10.1093/jac/dky556

"Moving Fourth": A Vision Toward Achieving Healthy Living with HIV Beyond Viral Suppression.

PMID: 31532396
Journal: AIDS REVIEWS
Year: 2019
Reference: AIDS Rev. 2019;21(3):135-142. doi: 10.24875/AIDSRev.19000088.
Impact factor: 2.357
Publication type: Paper in international publication
Authors: Verger, Christian, Guaraldi, Giovanni, Arends, Joop, Buhk, Thomas, Cascio, Mario, Curran, Adrian, Teofilo, Eugenio, Berk, Guido Van Den et al.
DOI: 10.24875/AIDSRev.19000088

"Moving Fourth": A Vision Toward Achieving Healthy Living with HIV Beyond Viral Suppression.

PMID: 31532396
Journal: AIDS REVIEWS
Year: 2019
Reference: AIDS Rev. 2019;21(3):135-142. doi: 10.24875/AIDSRev.19000088.
Impact factor:
Publication type: Paper in international publication
Authors: Arends, Joop; Berk, Guido Van Den; Buhk, Thomas; Cascio, Mario; Curran, Adrian; Guaraldi, Giovanni; Teofilo, Eugenio; Verger, Christian et al.
DOI: 10.24875/AIDSRev.19000088

Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.

PMID: 31050911
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2019
Reference: J Clin Oncol. 2019 Sep 1;37(25):2257-2269. doi: 10.1200/JCO.18.02050. Epub 2019 May 3.
Impact factor: 28.245
Publication type: Paper in international publication
Authors: Gourley, Charlie, Balmana, Judith, Ledermann, Jonathan A, Serra, Violeta, Dent, Rebecca, Loibl, Sibylle, Pujade-Lauraine, Eric, Boulton, Simon J et al.
DOI: 10.1200/JCO.18.02050

Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.

PMID: 31050911
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2019
Reference: J Clin Oncol. 2019 Sep 1;37(25):2257-2269. doi: 10.1200/JCO.18.02050. Epub 2019 May 3.
Impact factor:
Publication type: Paper in international publication
Authors: Balmana, Judith; Boulton, Simon J; Dent, Rebecca; Gourley, Charlie; Ledermann, Jonathan A; Loibl, Sibylle; Pujade-Lauraine, Eric; Serra, Violeta et al.
DOI: 10.1200/JCO.18.02050

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

PMID: 30155789
Journal: Brain Imaging and Behavior
Year: 2019
Reference: Brain Imaging Behav. 2019 Oct;13(5):1361-1374. doi: 10.1007/s11682-018-9942-9.
Impact factor: 3.418
Publication type: Paper in international publication
Authors: Sandbrink, Rupert, Sprenger, Till, Radue, Ernst-Wilhelm, Wuerfel, Jens, Nichols, Thomas E, Pohl, Christoph, Hartung, Hans-Peter, Montalban, Xavier, Freedman, Mark S, Bendfeldt, Kerstin et al.
DOI: 10.1007/s11682-018-9942-9

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

PMID: 30155789
Journal: Brain Imaging and Behavior
Year: 2019
Reference: Brain Imaging Behav. 2019 Oct;13(5):1361-1374. doi: 10.1007/s11682-018-9942-9.
Impact factor:
Publication type: Paper in international publication
Authors: Amann, Michael; Barkhof, Frederik; Bendfeldt, Kerstin; Borgwardt, Stefan; Edan, Gilles; Freedman, Mark S; Gaetano, Laura; Hartung, Hans-Peter; Kappos, Ludwig; Kloppel, Stefan et al.
DOI: 10.1007/s11682-018-9942-9

MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics.

PMID: 31877821
Journal: Pharmaceutics
Year: 2019
Reference: Pharmaceutics. 2019 Dec 21;12(1). pii: pharmaceutics12010016. doi: 10.3390/pharmaceutics12010016.
Impact factor: 4.773
Publication type: Paper in international publication
Authors: Rosell, Anna, Zhang, Yajie, Garcia-Gabilondo, Miguel, Roig, Anna et al.
DOI: 10.3390/pharmaceutics12010016

MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics.

PMID: 31877821
Journal: Pharmaceutics
Year: 2019
Reference: Pharmaceutics. 2019 Dec 21;12(1). pii: pharmaceutics12010016. doi: 10.3390/pharmaceutics12010016.
Impact factor:
Publication type: Paper in international publication
Authors: Garcia-Gabilondo, Miguel; Roig, Anna; Rosell, Anna; Zhang, Yajie et al.
DOI: 10.3390/pharmaceutics12010016

Mucosal RNA and Protein Expression as the next frontier in IBS: abnormal function despite morphologically intact small intestinal Mucosa.

PMID: 30767681
Journal: AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Year: 2019
Reference: Am J Physiol Gastrointest Liver Physiol. 2019 Jun 1;316(6):G701-G719. doi: 10.1152/ajpgi.00186.2018. Epub 2019 Feb 15.
Impact factor: 3.729
Publication type: Paper in international publication
Authors: Rodino-Janeiro, Bruno Kotska, Pardo-Camacho, Cristina, Santos, Javier, Martinez, Cristina et al.
DOI: 10.1152/ajpgi.00186.2018

Mucosal RNA and Protein Expression as the next frontier in IBS: abnormal function despite morphologically intact small intestinal Mucosa.

PMID: 30767681
Journal: AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Year: 2019
Reference: Am J Physiol Gastrointest Liver Physiol. 2019 Jun 1;316(6):G701-G719. doi: 10.1152/ajpgi.00186.2018. Epub 2019 Feb 15.
Impact factor:
Publication type: Paper in international publication
Authors: Martinez, Cristina; Pardo-Camacho, Cristina; Rodino-Janeiro, Bruno Kotska; Santos, Javier et al.
DOI: 10.1152/ajpgi.00186.2018

Multicenter clinical evaluation of a novel multiplex real-time PCR (qPCR) assay for detection of fluoroquinolone resistance in Mycoplasma genitalium.

PMID: 31434719
Journal: JOURNAL OF CLINICAL MICROBIOLOGY
Year: 2019
Reference: J Clin Microbiol. 2019 Oct 23;57(11). pii: JCM.00886-19. doi: 10.1128/JCM.00886-19. Print 2019 Nov.
Impact factor: 4.959
Publication type: Paper in international publication
Authors: Fernandez-Huerta, Miguel, Bodiyabadu, Kaveesha, Esperalba, Juliana, Bradshaw, Catriona S, Serra-Pladevall, Judit, Garland, Suzanne M, Fernandez-Naval, Candela, Jensen, Jorgen S, Pumarola, Tomas, Ebeyan, Samantha et al.
DOI: 10.1128/JCM.00886-19

Multicenter clinical evaluation of a novel multiplex real-time PCR (qPCR) assay for detection of fluoroquinolone resistance in Mycoplasma genitalium.

PMID: 31434719
Journal: JOURNAL OF CLINICAL MICROBIOLOGY
Year: 2019
Reference: J Clin Microbiol. 2019 Oct 23;57(11). pii: JCM.00886-19. doi: 10.1128/JCM.00886-19. Print 2019 Nov.
Impact factor:
Publication type: Paper in international publication
Authors: Bodiyabadu, Kaveesha; Bradshaw, Catriona S; Ebeyan, Samantha; Espasa, Mateu; Esperalba, Juliana; Fernandez-Huerta, Miguel; Fernandez-Naval, Candela; Garland, Suzanne M; Jensen, Jorgen S; Lundgren, Marie et al.
DOI: 10.1128/JCM.00886-19

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.

PMID: 31088831
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 Aug 15;25(16):4888-4897. doi: 10.1158/1078-0432.CCR-18-3334. Epub 2019 May 14.
Impact factor: 8.911
Publication type: Paper in international publication
Authors: Santiago-Walker, Ademi E, Poggesi, Italo, Parekh, Trilok, Xie, Hong, Infante, Jeffrey R, Tabernero, Josep, Zhong, Bob, Gonzalez, Martha D, Spira, Alexander I, Govindan, Ramaswamy et al.
DOI: 10.1158/1078-0432.CCR-18-3334

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.

PMID: 31088831
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 Aug 15;25(16):4888-4897. doi: 10.1158/1078-0432.CCR-18-3334. Epub 2019 May 14.
Impact factor:
Publication type: Paper in international publication
Authors: Awad, Mark M; Bahleda, Rastilav; Calvo, Emiliano; Cervantes, Andres; Chan, Nancy; Gonzalez, Martha D; Govindan, Ramaswamy; Hierro, Cinta; Infante, Jeffrey R; Italiano, Antoine et al.
DOI: 10.1158/1078-0432.CCR-18-3334

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.

PMID: 31506079
Journal: BMC Pediatrics
Year: 2019
Reference: BMC Pediatr. 2019 Sep 10;19(1):326. doi: 10.1186/s12887-019-1689-y.
Impact factor: 1.983
Publication type: Paper in international publication
Authors: Bartha, J M, Galindo, A, Martinez, J M, Gomez-Roig, L, Crispi, F, Gomez, O, Carreras, E, Cabero, L, Gratacos, E, Llurba, E et al.
DOI: 10.1186/s12887-019-1689-y

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.

PMID: 31506079
Journal: BMC Pediatrics
Year: 2019
Reference: BMC Pediatr. 2019 Sep 10;19(1):326. doi: 10.1186/s12887-019-1689-y.
Impact factor:
Publication type: Paper in international publication
Authors: Antolin, E; Arevalo, S; Bartha, J M; Boix, H; Cabero, L; Carreras, E; Comas, M; Crispi, F; Cruz-Lemini, M; Dolader, P et al.
DOI: 10.1186/s12887-019-1689-y

Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.

PMID: 31008727
Journal: ANTI-CANCER DRUGS
Year: 2019
Reference: Anticancer Drugs. 2019 Jul;30(6):628-635. doi: 10.1097/CAD.0000000000000794.
Impact factor: 1.801
Publication type: Paper in international publication
Authors: Casado, Antonio, Vicente, David, Ortega, Eugenia, Herrero, Ana, Guerra, Eva, Barretina-Ginesta, Pilar, Rubio, Maria J, Martinez, Alejandro, Bover, Isabel, Vidal, Laura et al.
DOI: 10.1097/CAD.0000000000000794

Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.

PMID: 31008727
Journal: ANTI-CANCER DRUGS
Year: 2019
Reference: Anticancer Drugs. 2019 Jul;30(6):628-635. doi: 10.1097/CAD.0000000000000794.
Impact factor:
Publication type: Paper in international publication
Authors: Arcusa, Angels; Barretina-Ginesta, Pilar; Bover, Isabel; Casado, Antonio; Del Campo, Jose M; Garcia, Yolanda; Gonzalez-Martin, Antonio; Gonzalez-Santiago, Santiago; Guerra, Eva; Herrero, Ana et al.
DOI: 10.1097/CAD.0000000000000794

Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

PMID: 30408481
Journal: CLINICA CHIMICA ACTA
Year: 2019
Reference: Clin Chim Acta. 2019 Jan;488:135-142. doi: 10.1016/j.cca.2018.11.008. Epub 2018 Nov 5.
Impact factor: 2.735
Publication type: Paper in international publication
Authors: Oterino, Agustin, Segundo, David San, Cuello, Juan Pablo, Gil-Herrera, Juana, Camara, Carmen, Gomez-Gutierrez, Montserrat, Martinez-Hernandez, Eugenia, Meca-Lallana, Virginia, Moga, Esther, Munoz-Calleja, Cecilia et al.
DOI: 10.1016/j.cca.2018.11.008

Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

PMID: 30408481
Journal: CLINICA CHIMICA ACTA
Year: 2019
Reference: Clin Chim Acta. 2019 Jan;488:135-142. doi: 10.1016/j.cca.2018.11.008. Epub 2018 Nov 5.
Impact factor:
Publication type: Paper in international publication
Authors: Alari-Pahissa, Elisenda; Aragon, Larraitz; Camara, Carmen; Castillo-Trivino, Tamara; Cuello, Juan Pablo; Eixarch, Herena; Ferrer, Joana Maria; Gascon-Gimenez, Francisco; Gil-Herrera, Juana; Gomez-Gutierrez, Montserrat et al.
DOI: 10.1016/j.cca.2018.11.008

Publications

Publications searcher

Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994-2013).

Mosunetuzumab Induces Complete Remissions in Poor Prognosis Non-Hodgkin Lymphoma Patients, Including Those Who Are Resistant to or Relapsing After Chimeric Antigen Receptor T-Cell (CAR-T) Therapies, and Is Active in Treatment through Multiple Lines.

Mosunetuzumab Induces Complete Remissions in Poor Prognosis Non-Hodgkin Lymphoma Patients, Including Those Who Are Resistant to or Relapsing After Chimeric Antigen Receptor T-Cell (CAR-T) Therapies, and Is Active in Treatment through Multiple Lines.

Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia.

"Moving Fourth": A Vision Toward Achieving Healthy Living with HIV Beyond Viral Suppression.

"Moving Fourth": A Vision Toward Achieving Healthy Living with HIV Beyond Viral Suppression.

Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.

Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics.

MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics.

Mucosal RNA and Protein Expression as the next frontier in IBS: abnormal function despite morphologically intact small intestinal Mucosa.

Mucosal RNA and Protein Expression as the next frontier in IBS: abnormal function despite morphologically intact small intestinal Mucosa.

Multicenter clinical evaluation of a novel multiplex real-time PCR (qPCR) assay for detection of fluoroquinolone resistance in Mycoplasma genitalium.

Multicenter clinical evaluation of a novel multiplex real-time PCR (qPCR) assay for detection of fluoroquinolone resistance in Mycoplasma genitalium.

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.

Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.

Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.

Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

Patronage:

Collaborating:

Accreditations: